Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OR2T2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | TGFB3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | PLEKHH3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | C1orf210 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | FPGT-TNNI3K | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | TKTL1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | MX2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | SEPSECS | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | CYP3A4 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | CCDC172 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |